What is it? ALTO-100 (previously NSI-189) is an oral drug being developed to treat major depressive disorder, bipolar depression, and PTSD by potentially enhancing brain cell growth and signaling, although its exact mechanism is unknown. What does science research say? What do user think? *Based on large scale analysis of publicly available user experiences, the…
What is it? Oxiracetam is a mild stimulant and nootropic drug that, despite being considered safe even at high doses, is not FDA-approved and has shown no convincing results in treating dementia symptoms in studies. What does science research say? What do user think? *Based on large scale analysis of publicly available user experiences, the…
What is it? Aniracetam is a nootropic drug sold in Europe for improving memory and treating dementia, not FDA-approved in the U.S. but available over-the-counter, with studies showing it enhances learning and has mild anti-anxiety effects. What does science research say? What do user think? *Based on large scale analysis of publicly available user experiences,…